文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克去复苏研究进展

[Advances in the study of de-resuscitation in septic shock].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论脓毒性休克液体复苏后需警惕液体蓄积综合征,后期积极去复苏联合血流动力学监测等措施可能减少液体正平衡、降低器官功能障碍风险、缩短ICU住院时间。

脓毒性休克初始管理需要充分液体复苏以恢复组织灌注,但过多或持续的液体输注可能诱发液体蓄积综合征(FAS),显著增加器官功能障碍和死亡风险。去复苏作为预防或纠正FAS的关键阶段,为改善患者预后提供了重要机会。近期研究显示,在脓毒性休克复苏后期,积极去复苏联合血流动力学监测、调整血管活性药物等综合干预措施,有助于减少液体正平衡、降低器官功能障碍风险、缩短ICU住院时间并改善预后。目前去复苏的时机、容量评估方法、个体化方案的制定及并发症防控是研究焦点,寻找可靠生物标志物指导去复苏策略将成为未来热点。本文综述FAS的病理生理与临床诊断、脓毒性休克去复苏的临床策略、争议与挑战,并探讨未来研究方向。

要点

  • 脓毒性休克初始需充分液体复苏恢复组织灌注,但过多或持续液体输注可能诱发液体蓄积综合征(FAS),显著增加器官功能障碍和死亡风险。
  • 去复苏是预防或纠正FAS的关键阶段,为改善脓毒性休克患者预后提供重要机会。
  • 近期研究显示,脓毒性休克复苏后期积极去复苏联合血流动力学监测、调整血管活性药物等综合干预,有助于减少液体正平衡、降低器官功能障碍风险、缩短ICU住院时间并改善预后。
  • 去复苏的时机、容量评估方法、个体化治疗方案制定及相关并发症防控是当前研究焦点。
  • 寻找可靠生物标志物指导去复苏策略将成为未来研究热点。

适用人群与场景

  • 脓毒性休克患者,处于液体复苏后期阶段。

诊断标准与关键阈值

  • 液体蓄积综合征(FAS):原文提及对其病理生理和临床诊断进行综述,但未给出具体诊断标准或阈值。

处置流程与药物剂量

  • 脓毒性休克复苏后期可进行积极去复苏,联合血流动力学监测、调整血管活性药物等综合干预措施,以帮助减少液体正平衡、降低器官功能障碍风险、缩短ICU住院时间并改善预后。

研究设计与关键结果

  • 综述指出,脓毒性休克初始充分液体复苏后,过多或持续液体输注可能诱发液体蓄积综合征(FAS),显著增加器官功能障碍和死亡风险;复苏后期积极去复苏联合血流动力学监测、调整血管活性药物等综合干预措施可能有助于减少液体正平衡、降低器官功能障碍风险、缩短ICU住院时间并改善预后。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒性休克复苏后期积极去复苏联合血流动力学监测、调整血管活性药物等综合干预措施可能有助于减少液体正平衡、降低器官功能障碍风险、缩短ICU住院时间并改善预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The initial management of septic shock necessitates adequate fluid resuscitation to restore tissue perfusion. However, excessive or sustained fluid administration may precipitate fluid accumulation syndrome (FAS), significantly exacerbating the risk of organ dysfunction and mortality. Consequently, proactive prevention and management of FAS are paramount for optimizing patient outcomes. With the continuous optimization of fluid resuscitation strategies in the treatment of septic shock, de-resuscitation, as a key stage for preventing or correcting FAS, provides an important opportunity to improve patient prognosis. Recent studies have shown that during the later phase of septic shock resuscitation, active de-resuscitation combined with hemodynamic monitoring, adjustment of vasoactive drugs and other comprehensive intervention measures can help reduce fluid positive balance, lower the risk of organ dysfunction, shorten the length of intensive care unit (ICU) stay, and improve patient prognosis. Currently, the timing of de-resuscitation, volume assessment methods, the development of individualized treatment protocols, and the prevention and control of related complications have become the focus of research, while the search for reliable biomarkers to guide de-resuscitation strategies will become a future hot direction. In this article, we review the pathophysiology and clinical diagnosis of FAS, as well as the clinical strategies, controversies and challenges of de-resuscitation in septic shock, and explore the future research directions of de-resuscitation strategies, with the aim of providing theoretical basis and practical guidance for optimizing fluid management in patients with septic shock.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yao W, Gao Y, Kou C, et al. [Advances in the study of de-resuscitation in septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41437592. doi:10.3760/cma.j.cn121430-20250428-00404

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。